Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7
about
The Janus kinases (Jaks)Janus kinases in immune cell signalingIL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3)Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation.RNA sequencing reveals region-specific molecular mechanisms associated with epileptogenesis in a model of classical hippocampal sclerosisThe Csk-like proteins Lsk, Hyl, and Matk represent the same Csk homologous kinase (Chk) and are regulated by stem cell factor in the megakaryoblastic cell line MO7eExpression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cellsInduction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytesJAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cellsJak3 negatively regulates dendritic-cell cytokine production and survivalCo-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment.Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activityThe molecular regulation of Janus kinase (JAK) activationInterleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway.Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytesJak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.Hck is a key regulator of gene expression in alternatively activated human monocytesPhosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activityBiology and significance of the JAK/STAT signalling pathways.Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency.JAK2-STAT5B pathway and osteoblast differentiation.Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.Binding of IL-4 to the IL-13Ralpha(1)/IL-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation.Signal transduction pathways induced by GM-CSF in microglia: significance in the control of proliferation.Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells.JAK2 is necessary and sufficient for interferon-gamma-induced transcription of the gene encoding gp91PHOX.Effect of CP-690,550, an orally active janus kinase inhibitor, on renal function in healthy adult volunteers.Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis.
P2860
Q21194856-1E49BC13-B7A0-42CA-8640-07DC21C65B56Q24322021-FCC59B40-767D-4668-9DA5-95D4A5F2539CQ24597508-7C7EE017-6A1D-47B8-80E4-40AA68834371Q24806655-0B86427F-341F-4DD5-8ECD-3096D7F2D294Q27334971-44D4AE82-68CC-4B0A-AC31-AC4AC1E3EBEAQ28246125-6040F7BC-2F9B-4088-8F5A-AA8ADBEC6395Q28281733-6DA001B4-0DB5-44B7-B346-8A7DE2937AACQ28289279-79F168B6-64A4-4FF8-9344-7334E4BA5C5DQ28584039-C1C8294D-A4B4-4FC1-A12A-4C1761613174Q28586242-1EBA87DD-41CB-434D-8CFC-484ED5606EFDQ33668201-DE522997-4314-4859-85AA-DC90729FAB13Q33731594-F7331659-6ABD-42A9-A92C-D864B7F35936Q33956113-EE3BBEF9-1B1A-48F1-ABF3-8C250FD077EAQ34171181-7610A094-DC00-4F6B-9EB7-185E2AEAFE5FQ34344987-A6C28775-3D85-4031-8D89-FC97013D90F5Q34386311-5B9E68FF-5FAD-483E-BB65-E73538E520ECQ35378767-91158C86-EF3E-4B7F-BF20-2F29F61412D7Q36498064-908F323F-DB4F-4AC5-963C-AFF76D0E7396Q37146441-4B734686-358A-4251-97F2-53D2593BD27FQ37362415-D658D678-50BB-4998-A9CE-0FB39FE29FF8Q37488170-5BAF7668-58BF-4A0A-9CA1-CB62E481B6BFQ38837769-49C317EA-6ED6-4D0C-A8E6-F1EF2D1F40EFQ39185214-25C23730-7565-44C9-A744-3B65FE0E3EFDQ40909988-7E59589E-794B-4E93-A6B3-EB132B2D25A1Q40945904-6238A343-D9A2-4D03-BCBE-D1A8AE7602CFQ41089157-83316645-8CE9-48A7-A496-EE948131D990Q42122378-E69E1E60-7017-4E71-B586-D90FACACA724Q43480803-B62E6E19-6F8B-40AF-8044-9B25C975E05CQ45116949-75E1C561-D69F-4246-90DB-748448BCFEC4Q46076169-DC8B94C0-D4B7-462C-8D59-450BE0534381Q52626728-18668EFD-7723-4CB3-8F07-E7B4062ECFF7
P2860
Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@ast
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@en
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@nl
type
label
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@ast
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@en
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@nl
prefLabel
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@ast
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@en
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@nl
P2093
P2860
P356
P1476
Regulation of JAK3 expression ...... se to interleukins 2, 4, and 7
@en
P2093
D Linnekin
D W McVicar
J A Johnston
J J O'Shea
P2860
P304
P356
10.1084/JEM.181.4.1425
P407
P577
1995-04-01T00:00:00Z